Literature DB >> 19836216

Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat.

R Przybylski1, S McCune, B Hollis, R U Simpson.   

Abstract

BACKGROUND AND AIMS: Vitamin D deficiency has been associated with the etiology and pathogenesis of heart disease including congestive heart failure. We previously observed cardiac hypertrophy in vitamin D deficient rats and vitamin D receptor knockout mice. These studies indicate that the absence of vitamin D-mediated signal transduction and genomic activation results in increased sensitivity of the heart to ionotropic stimuli and cardiomyocyte hypertrophy. This study's aim is to investigate the relationship between vitamin D status and the heart failure phenotype in the rat. METHODS AND
RESULTS: Vitamin D status was assessed by measuring 25-hydroxyvitamin D levels and related to heart weight in young, middle-aged and aging spontaneously hypertensive, heart failure (SHHF) prone rats. We also measured the effects of the vitamin D hormone,1,25(OH)(2)D(3), on cardiac function in SHHF rats. Cardiac hypertrophy in this model of the failing heart increased with age and related to decreasing vitamin D status. Vitamin D deficiency presented after cardiac hypertrophy was first observed. Additionally, we found that 1,25(OH)(2)D(3) treatment between 4.0 and 7.0 months of age prevented cardiac hypertrophy and permits decreased workload for the heart while allowing adequate blood perfusion and pressure, resulting in reduced cardiac index.
CONCLUSIONS: Our findings suggest that low vitamin D status is associated with the progression and final terminal phase of the heart failure phenotype and not with initial heart hypertrophy. Also, we report that in the vitamin D sufficient SHHF rat, 1,25(OH)(2)D(3) treatment provided protection against the progression of the heart failure phenotype.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836216      PMCID: PMC2889219          DOI: 10.1016/j.numecd.2009.07.009

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  34 in total

1.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Circulating vitamin D3 and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status.

Authors:  Bruce W Hollis; Carol L Wagner; Mark K Drezner; Neil C Binkley
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-10       Impact factor: 4.292

4.  Protein kinase C isozymes in hypertension and hypertrophy: insight from SHHF rat hearts.

Authors:  Dustin D Johnsen; Rachid Kacimi; Brent E Anderson; Tracy A Thomas; Suleman Said; A Martin Gerdes
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

Review 5.  Involvement of 1,25-dihydroxyvitamin D3 in regulating myocardial calcium metabolism: physiological and pathological actions.

Authors:  R U Simpson; R E Weishaar
Journal:  Cell Calcium       Date:  1988-12       Impact factor: 6.817

6.  Vitamin D3 and cardiovascular function in rats.

Authors:  R E Weishaar; R U Simpson
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Structural, functional, and molecular characterization of the SHHF model of heart failure.

Authors:  Jonathan R R Heyen; Eileen R Blasi; Kristen Nikula; Ricardo Rocha; Heather A Daust; Gregory Frierdich; John F Van Vleet; Pam De Ciechi; Ellen G McMahon; Amy E Rudolph
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

Review 8.  Overview of general physiologic features and functions of vitamin D.

Authors:  Hector F DeLuca
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

9.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.

Authors:  Ken C Chiu; Audrey Chu; Vay Liang W Go; Mohammed F Saad
Journal:  Am J Clin Nutr       Date:  2004-05       Impact factor: 7.045

10.  Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats.

Authors:  M Inoko; Y Kihara; I Morii; H Fujiwara; S Sasayama
Journal:  Am J Physiol       Date:  1994-12
View more
  12 in total

Review 1.  Vitamin D and the heart.

Authors:  David G Gardner; Songcang Chen; Denis J Glenn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-11       Impact factor: 3.619

2.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

3.  Impact of vitamin D3 on cardiovascular responses to glucocorticoid excess.

Authors:  Mona A Ahmed
Journal:  J Physiol Biochem       Date:  2012-09-19       Impact factor: 4.158

Review 4.  Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.

Authors:  Jonathan P Law; Luke Pickup; Davor Pavlovic; Jonathan N Townend; Charles J Ferro
Journal:  J Hum Hypertens       Date:  2022-09-22       Impact factor: 2.877

Review 5.  Vitamin D and Calcimimetics in Cardiovascular Disease.

Authors:  Kenneth Lim; Takayuki Hamano; Ravi Thadhani
Journal:  Semin Nephrol       Date:  2018-05       Impact factor: 5.299

6.  Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.

Authors:  G Youcef; A Olivier; N Nicot; A Muller; C Deng; C Labat; R Fay; R-M Rodriguez-Guéant; C Leroy; F Jaisser; F Zannad; P Lacolley; L Vallar; A Pizard
Journal:  Br J Pharmacol       Date:  2016-04-26       Impact factor: 8.739

Review 7.  What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?

Authors:  Sharon M Moe; Ravi Thadhani
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

8.  Reduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).

Authors:  Gabriella Masszi; Eszter Maria Horvath; Robert Tarszabo; Rita Benko; Agnes Novak; Anna Buday; Anna-Maria Tokes; Gyorgy L Nadasy; Peter Hamar; Zoltán Benyó; Szabolcs Varbiro
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Potential role of vitamin D deficiency on Fabry cardiomyopathy.

Authors:  Christiane Drechsler; Benjamin Schmiedeke; Markus Niemann; Daniel Schmiedeke; Johannes Krämer; Irina Turkin; Katja Blouin; Andrea Emmert; Stefan Pilz; Barbara Obermayer-Pietsch; Frank Weidemann; Frank Breunig; Christoph Wanner
Journal:  J Inherit Metab Dis       Date:  2013-10-19       Impact factor: 4.982

10.  Simultaneous characterization of metabolic, cardiac, vascular and renal phenotypes of lean and obese SHHF rats.

Authors:  Gina Youcef; Arnaud Olivier; Clément P J L'Huillier; Carlos Labat; Renaud Fay; Lina Tabcheh; Simon Toupance; Rosa-Maria Rodriguez-Guéant; Damien Bergerot; Frédéric Jaisser; Patrick Lacolley; Faiez Zannad; Anne Pizard
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.